Blood markers of coagulation, fibrinolysis and inflammation in COVID-19
Blood test | Direction of change | Comparator (case vs control) | Reference(s) |
D-dimer | ↑ | Severe versus non-severe | 17 |
Fibrinogen | ↑ | ICU versus ref range | 16 |
Platelets | → / ↓ | Severe versus non-severe | 17 101 |
aPTT | → | Severe versus non-severe | 17 90 |
PT | → / ↑ | Severe versus non-severe | 17 102 |
Antithrombin | → / ↑ | COVID-19 versus healthy control | 103 |
PAI-1 | ↑ | Autopsy versus ref range | 43 |
Leucocytes | ↑ | Severe versus non-severe | 17 |
Lymphocytes | ↓ | Severe versus non-severe | 17 |
Neutrophils | ↑ | Severe versus non-severe | 17 |
Factor VIII | ↑ | ICU versus non-ICU | 39 |
VWF | ↑ | ICU versus non-ICU | 39 |
Soluble P-selectin | ↑ | ICU versus non-ICU | 39 |
CRP | ↑ | Severe versus non-severe | 17 |
Procalcitonin | ↑ | Severe versus non-severe | 17 90 |
Ferritin | ↑ | Severe versus non-severe | 90 |
Complement | ↑ | Autopsy versus ref range | 64 |
Arrows indicate the direction of change (↑=increase, ↓=decrease, →=no change) in COVID-19 with respect to a control group or reference range defined in the comparator column. The magnitude of change (ie, marked increase vs mild increase) is not indicated in this table.
aPTT, activated partial thromboplastin time; CRP, C reactive protein; ICU, intensive care unit; PAI-1, plasminogen activator inhibitor 1; PT, prothrombin time; ref, reference; VWF, von Willebrand factor.